1-20 of 24
Robert Redd
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune population changes after glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with follicular lymphoma and marginal zone lymphoma

Free
Emily Sumpena, Ioulia Vogiatzi, Arsh Patel, Heather Walker, Jenna Mahns, Robert Redd, Philippe Armand, Reid Merryman, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 5344.
https://doi.org/10.1182/blood-2025-5344
Published: 2025
Journal Articles

Phase I/II study of acalabrutinib, venetoclax, and obinutuzumab in patients with relapsed/refractory and previously untreated Mantle Cell Lymphoma (MAVO)

Free
Austin Kim, Peter Riedell, Christine Ryan, Robert Redd, Clare Phinney, Juniper Mai, Samantha Pazienza, Caitlin Bravo, Vanessa Kats, Salah Abdulkarim, Susan Waisgerber, Reid Merryman, David Fisher, Inhye Ahn, Jennifer Crombie, Oreofe Odejide, Ann LaCasce, Caron Jacobson, Eric Jacobsen, Erin Parry, David Qualls, Amy Bessnow, Matthew S Davids, Jennifer Brown, Jon Arnason, Michael Leukam, Philippe Armand, Justin Kline, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 664.
https://doi.org/10.1182/blood-2025-664
Published: 2025
Journal Articles

Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial

Free
Reid Merryman, Gottfried von Keudell, Robert Redd, Heather Walker, Jenna Mahns, Samantha Normilus, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Hua-Jay Cherng, Mark Murakami, Philippe Armand, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2025-3602
Published: 2025
Journal Articles

Thrombosis, bleeding, and progression in JAK2 V617F clonal hematopoiesis

Free
Rathnam Venkat, Robert Redd, Gabriela Hobbs, Chi-Joan How
Journal: Blood
Blood (2025) 146 (Supplement 1): 3168.
https://doi.org/10.1182/blood-2025-3168
Published: 2025
Journal Articles

Optimizing fludarabine: The impact of fludarabine renal dose adjustment during lymphodepletion prior to CAR-T cell immunotherapy in multiple myeloma patients

Free
Lara Abousamra, Sylvia Truong, Houry Leblebjian, Robert Redd, Omar Nadeem
Journal: Blood
Blood (2025) 146 (Supplement 1): 826.
https://doi.org/10.1182/blood-2025-826
Published: 2025
Journal Articles

Outcomes of CD20xCD3 bispecific antibody therapy in adult patients with Relapsed/Refractory transformed indolent lymphoma

Free
Pierre Stephan, Karan Chohan, Robert Redd, Sairah Ahmed, Christopher Flowers, Ayushi Chauhan, Amy Ayers, Geoffrey Shouse, Swetha Thiruvengadam, Alex Herrera, Allison Bock, Narendranath Epperla, Shannon Buckley, Boyu Hu, Matthew Lunning, Gilles Salles, Lorenzo Falchi, Yazeed Sawalha, Sonia Godbole, Andrew Jallouk, Shakthi Bhaskar, Ajay Major, Steven Bair, Philippe Armand, Reid Merryman, Alexey Danilov, Jennifer Crombie
Journal: Blood
Blood (2025) 146 (Supplement 1): 5521.
https://doi.org/10.1182/blood-2025-5521
Published: 2025
Journal Articles

Outcomes and prognostic factors in patients with follicular lymphoma treated with front-line bendamustine and rituximab

Free
Hari Raman, Robert Redd, Wendy Dixon, Pari Ahmadi, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Mark Murakami, Philippe Armand, Reid Merryman
Journal: Blood
Blood (2025) 146 (Supplement 1): 1812.
https://doi.org/10.1182/blood-2025-1812
Published: 2025
Journal Articles

Immune cell dynamics following rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma

Free
Ioulia Vogiatzi, Emily Sumpena, Arsh Patel, Heather Walker, Rafaella Tringale, Robert Redd, Philippe Armand, Reid Merryman, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 1790.
https://doi.org/10.1182/blood-2025-1790
Published: 2025
Journal Articles

Results of the Phase II d-PRISM study: Daratumumab in high-risk MGUS and low-risk smoldering myeloma

Free
Omar Nadeem, Michelle Aranha, Robert Redd, Michael Koontz, Jeffrey Matous, Andrew Yee, Jeffrey Zonder, Andrew Kin, Sophie Magidson, Elizabeth Lightbody, Ting Wu, Floris Chabrun, Jean-Baptiste Alberge, Ankit Dutta, Jacqueline Perry, Ashlee Sturtevant, Mahshid Rahmat, Junko Tsuji, Christine Davie, Caroline Ricciardi, Frances Arters, Marjorie Marto, Amy Goguen, Jacalyn Rosenblatt, Elizabeth O'Donnell, Jacob Laubach, Paul Richardson, Gad Getz, Lorenzo Trippa, Romanos Sklavenitis-Pistofidis, Irene Ghobrial
Journal: Blood
Blood (2025) 146 (Supplement 1): 1533.
https://doi.org/10.1182/blood-2025-1533
Published: 2025
Journal Articles

Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

Free
Lachelle Weeks, Courtney Fitzhugh, Sam Pollock, Miriam Osei, Micah Rickles-Young, H. Moses Murdock, Megan Townsend, Christopher Reilly, Carla Dinardo, Ester Sabino, Mark Fleharty, Matthew DeFelice, Azeet Narayan, Donna Neuberg, Robert Redd, Lakshmanan Krishnamurti, David Williams, Pablo Bartolucci, Carrie Cibulskis, Julia Smith, Milena Batchvarova, Nancy Asomaning, Brian Custer, Kolapo Oyebola, Carlo Brugnara, Russell Ware, Vivien Sheehan, Jeffrey Glassberg, Shannon Kelly, Swee Lay Thein, Allison Ashley-Koch, Marilyn Telen, Guillaume Lettre, Niall Lennon, R. Coleman Lindsley
Journal: Blood
Blood (2025) 146 (Supplement 1): 8.
https://doi.org/10.1182/blood-2025-8
Published: 2025
Journal Articles

Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial

Free
Reid Merryman, Danielle Wallace, Robert Redd, Heather Walker, Rafaella Tringale, Vanessa Kats, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Audrey Sigmund, Inhye Ahn, Amy Bessnow, Jennifer R. Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Sumana Devata, Carla Casulo, Kami Maddocks, Mark Murakami, Philippe Armand, Yazeed Sawalha
Journal: Blood
Blood (2025) 146 (Supplement 1): 464.
https://doi.org/10.1182/blood-2025-464
Published: 2025
Journal Articles

DLB class : a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma

Available to Purchase
Björn Chapuy, Timothy Wood, Chip Stewart, Andrew Dunford, Kirsty Wienand, Sumbul Jawed Khan, Nazli Serin, Meng Wang, Eleonora Calabretta, Joji Shimono, Samantha Van Seters, Sam Wisemann, Saveliy Belkin, David Heimann, Robert Redd, Margaret A. Shipp, Gad Getz
Journal: Blood
Blood (2025) 145 (18): 2041–2055.
https://doi.org/10.1182/blood.2024025652
Published: 2025
Includes: Supplemental data
Journal Articles

Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma

Free
Clinical Trials & Observations
Katie Maurer, Isabella N. Grabski, Roch Houot, Satyen H. Gohil, Shogo Miura, Robert Redd, Haoxiang Lyu, Wesley Lu, Yohei Arihara, Justin Budka, Mikaela McDonough, Michela Ansuinelli, Carol Reynolds, Heather Jacene, Shuqiang Li, Kenneth J. Livak, Jerome Ritz, Brodie Miles, Mike Mattie, Donna S. Neuberg, Rafael A. Irizarry, Philippe Armand, Catherine J. Wu, Caron Jacobson
Journal: Blood
Blood (2024) 144 (24): 2490–2502.
https://doi.org/10.1182/blood.2024024381
Published: 2024
Includes: Supplemental data
Journal Articles

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia

Open Access
Clinical Trials & Observations
Lachelle D. Weeks, Catherine R. Marinac, Robert Redd, Gregory Abel, Amy Lin, Mridul Agrawal, Richard M. Stone, Deborah Schrag, Benjamin L. Ebert
Journal: Blood
Blood (2022) 139 (8): 1246–1250.
https://doi.org/10.1182/blood.2021014418
Published: 2022
Includes: Supplemental data
Journal Articles

Mapping Myeloma: A Roadmap of Daratumumab Use in Clinical Pathways

Free
Shahrier Hossain, Houry Leblebjian, David M Jackman, Jacob P. Laubach, Clifton C. Mo, Paul G. Richardson, Emily Foster, Ariel Martin-Quashie, Robert Redd, Omar Nadeem
Journal: Blood
Blood (2021) 138 (Supplement 1): 4021.
https://doi.org/10.1182/blood-2021-149482
Published: 2021
Journal Articles

Clonal Hematopoiesis Is Frequent and Associated with Inferior Survival Irrespective of Transplantation Strategy in Patients with Newly Diagnosed Multiple Myeloma

Free
Adam S. Sperling, Robert Redd, Christopher J. Gibson, Peter G. Miller, Jill Corre, Philippe Moreau, Donna S. Neuberg, Mehmet K. Samur, Benjamin L. Ebert, Herve Avet-Loiseau, Nikhil C. Munshi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1127.
https://doi.org/10.1182/blood-2021-148050
Published: 2021
Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Free
Christopher R. Reilly, Mikko Myllymäki, Robert Redd, Shilpa Padmanaban, Druha Karunakaran, Valerie Tesmer, Frederick D. Tsai, Christopher J. Gibson, Huma Q. Rana, Liang Zhong, Wael Saber, Stephen R. Spellman, Zhen-Huan Hu, Esther H. Orr, Maxine M. Chen, Immaculata De Vivo, Daniel J. DeAngelo, Corey Cutler, Joseph H. Antin, Donna Neuberg, Judy E. Garber, Jayakrishnan Nandakumar, Suneet Agarwal, R. Coleman Lindsley
Journal: Blood
Blood (2021) 138 (10): 898–911.
https://doi.org/10.1182/blood.2021011075
Published: 2021
Includes: Supplemental data
Journal Articles

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Free
Clinical Trials & Observations
Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen-Huan Hu, Tao Wang, Esther H. Orr, Jaclyn G. Grenier, Maxine M. Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley
Journal: Blood
Blood (2020) 136 (26): 3070–3081.
https://doi.org/10.1182/blood.2020005397
Published: 2020
Includes: Supplemental data
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma: Results from Phase I Dose Escalation Cohorts

Free
Omar Nadeem, MD, Clifton C Mo, MD, Jacob P. Laubach, MD, Giada Bianchi, MD, Robert Redd, Peter Barth, Trevor J. Bayliss, MD, Vaishali Sanchorawala, MD, Leyla Shune, MD, Alexandra Distaso, Virginia Dalton, MS, APRN, Adam S Sperling, MD PhD, Laura Amweg, Mary McKenney, NP, Kathleen Colson, BS,BSN,RN, Ella L Millard, Isabella Hou, Alexandra Savell, BS, Kelly Masone, BA, Nikhil C. Munshi, MD, Irene M. Ghobrial, MD, Kenneth Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-141549
Published: 2020
Journal Articles

A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety

Free
Omar Nadeem, MD, Robert Redd, Laura V. Stampleman, Jeffrey V. Matous, MD, Andrew J. Yee, MD, Jeffrey A. Zonder, Andrew Kin, MD, Jacalyn Rosenblatt, MD, Mark Bustoros, MD, Julia Prescott, MSN,NP, Alexandra Savell, BS, Kathleen Guimond, RN, Erin Frey, RN, Rachel Styles, BS, Adrienne Bielawski, Cody J Boehner, BS, Nang Kham Su, BA, Multiple Myeloma Research Foundation Multiple Myeloma Research Foundation, The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society, BCRP Blood Cancer Research Partnership, Adam S Sperling, MD PhD, Giada Bianchi, MD, Jacob P. Laubach, MD, Jorge J. Castillo, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Lorenzo Trippa, Irene M. Ghobrial, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1898.
https://doi.org/10.1182/blood-2019-129103
Published: 2019